|
ACER2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.119800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.141800E-01 |
| Normal-vs-Stage2 |
3.629200E-01 |
| Normal-vs-Stage3 |
1.063240E-01 |
| Normal-vs-Stage4 |
3.276300E-02 |
| Stage1-vs-Stage2 |
7.011400E-01 |
| Stage1-vs-Stage3 |
9.801400E-04 |
| Stage1-vs-Stage4 |
1.10939999997672E-06 |
| Stage2-vs-Stage3 |
5.463600E-02 |
| Stage2-vs-Stage4 |
1.658600E-03 |
| Stage3-vs-Stage4 |
5.813600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.408800E-01 |
| Normal-vs-AfricanAmerican |
7.187700E-02 |
| Normal-vs-Asian |
5.670600E-01 |
| Caucasian-vs-AfricanAmerican |
2.764200E-02 |
| Caucasian-vs-Asian |
6.624800E-01 |
| AfricanAmerican-vs-Asian |
2.605800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.869630E-01 |
| Normal-vs-Female |
2.711400E-01 |
| Male-vs-Female |
3.060200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.152600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.195400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.581380E-01 |
| Normal-vs-Age(81-100Yrs) |
1.813570E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.836640E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.570600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.441800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.017500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.807400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.991800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.660000E-01 |
| Normal-vs-Grade 2 |
3.835600E-01 |
| Normal-vs-Grade 3 |
1.700420E-01 |
| Normal-vs-Grade 4 |
1.992080E-02 |
| Grade 1-vs-Grade 2 |
1.216000E-02 |
| Grade 1-vs-Grade 3 |
9.440400E-04 |
| Grade 1-vs-Grade 4 |
2.240400E-03 |
| Grade 2-vs-Grade 3 |
1.913540E-02 |
| Grade 2-vs-Grade 4 |
7.77209996360995E-09 |
| Grade 3-vs-Grade 4 |
1.364110E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.930600E-01 |
| Normal-vs-ccB subtype |
1.237220E-01 |
| ccA subtype-vs-ccB subtype |
3.76869999985097E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.272800E-01 |
| Normal-vs-N1 |
5.244000E-02 |
| N0-vs-N1 |
1.068220E-01 |
|
|
